Mediwound Share Price (NASDAQ: MDWD)

$17.44

Live

Last updated on August 22, 2025 at 12:36 AM IST

$₹

Check the interactive Mediwound Stock chart to analyse performance

Mediwound stock performance

as on August 22, 2025 at 12:36 AM IST

Today's Low:$17.44
Today's High:$17.49
$17.44
0.0%
Downside
Day's Volatility :0.29%
Upside
0.29%
52 Weeks Low:$14.14
52 Weeks High:$22.51
$17.44
18.92%
Downside
52 Weeks Volatility :37.17%
Upside
22.51%

Mediwound Stock Returns

Period	Mediwound Ltd	Index (Russel 2000)
3 Months	-14.28%	0.0%
6 Months	-6.31%	0.0%
1 Year	-6.96%	0.0%
3 Years	23.0%	-9.6%

Mediwound Ltd Key Stats

Check Mediwound key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$17.44
Open	$17.55
Today's High	$17.49
Today's Low	$17.34
Market Capitalization	$191.4M
Today's Volume	$92.2K
52 Week High	$22.505
52 Week Low	$14.14
Revenue TTM	$19.9M
EBITDA	$-21.3M
Earnings Per Share (EPS)	$-2.6
Profit Margin	-142.18%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-148.65%

Stock Returns calculator for Mediwound Stock including INR - Dollar returns

The Mediwound stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Mediwound investment value today

Current value as on today

₹96,990

Returns

₹3,010

(-3.01%)

Returns from Mediwound Stock

₹6,937 (-6.94%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Mediwound Stock

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Mediwound Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mediwound Ltd

Name
Holdings %
Name
Holdings %
Investors Finance Co PLC
8.07%
Yelin Lapidot Holdings Management Ltd
7.56%
Rosalind Advisors, Inc.
4.69%
BlackRock Inc
4.39%
T. Rowe Price Associates, Inc.
3.47%
Northern Trust Corp
1.36%

Analyst Recommendation on Mediwound Stock

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Mediwound(by analysts ranked 0 to 5 stars)

Mediwound Share Price Target

What analysts predicted

Upside of 75.84%

Target:

$30.67

Current:

$17.44

Mediwound share price target is $30.67, a slight Upside of 75.84% compared to current price of $17.44 as per analysts' prediction.

Mediwound Stock Insights

Price Movement
In the last 7 days, MDWD stock has moved down by -6.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 3.95M → 5.70M (in $), with an average increase of 30.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -726.0K → -13.31M (in $), with an average decrease of 1734.4% per quarter
MDWD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 71.1%
MDWD vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.1% return, outperforming this stock by 92.4%
Price to Sales
ForMDWD every $1 of sales, investors are willing to pay $9.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.1 for every $1 of sales.

Mediwound Ltd Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$31.8M	↑ 834.7%
Net Income	$5.0M	↓ 568.78%
Net Profit Margin	15.59%	↑ 46.67%

	FY20	Y/Y Change
Revenue	$21.8M	↓ 31.54%
Net Income	$-9.2M	↓ 285.59%
Net Profit Margin	-42.26%	↓ 57.85%

	FY21	Y/Y Change
Revenue	$23.8M	↑ 9.19%
Net Income	$-13.6M	↑ 47.36%
Net Profit Margin	-57.03%	↓ 14.77%

	FY22	Y/Y Change
Revenue	$26.5M	↑ 11.5%
Net Income	$-19.6M	↑ 44.63%
Net Profit Margin	-73.97%	↓ 16.94%

	FY23	Y/Y Change
Revenue	$18.7M	↓ 29.48%
Net Income	$-6.7M	↓ 65.73%
Net Profit Margin	-35.94%	↑ 38.03%

	FY24	Y/Y Change
Revenue	$20.2M	↑ 8.22%
Net Income	$-30.2M	↑ 350.03%
Net Profit Margin	-149.46%	↓ 113.52%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$5.0M	↓ 7.01%
Net Income	$-9.7M	↑ 458.18%
Net Profit Margin	-195.99%	↓ 163.34%

	Q2 FY24	Q/Q Change
Revenue	$5.1M	↑ 1.99%
Net Income	$-6.3M	↓ 35.19%
Net Profit Margin	-124.53%	↑ 71.46%

	Q3 FY24	Q/Q Change
Revenue	$4.4M	↓ 13.98%
Net Income	$-10.3M	↑ 63.08%
Net Profit Margin	-236.1%	↓ 111.57%

	Q4 FY24	Q/Q Change
Revenue	$5.8M	↑ 34.1%
Net Income	$-3.9M	↓ 61.99%
Net Profit Margin	-66.92%	↑ 169.18%

	Q1 FY25	Q/Q Change
Revenue	$4.0M	↓ 32.28%
Net Income	$-726.0K	↓ 81.42%
Net Profit Margin	-18.36%	↑ 48.56%

	Q2 FY25	Q/Q Change
Revenue	$5.7M	↑ 44.32%
Net Income	$-13.3M	↑ 1734.44%
Net Profit Margin	-233.32%	↓ 214.96%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$19.9M	↑ 1418.66%

	FY20	Y/Y Change
Profit	$7.5M	↓ 62.16%

	FY21	Y/Y Change
Profit	$8.8M	↑ 16.25%

	FY22	Y/Y Change
Profit	$13.2M	↑ 50.1%

	FY23	Y/Y Change
Profit	$3.6M	↓ 72.82%

	FY24	Y/Y Change
Profit	$2.6M	↓ 26.38%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$607.0K	↓ 15.58%

	Q2 FY24	Q/Q Change
Profit	$447.0K	↓ 26.36%

	Q3 FY24	Q/Q Change
Profit	$677.0K	↑ 51.45%

	Q4 FY24	Q/Q Change
Profit	$903.0K	↑ 33.38%

	Q1 FY25	Q/Q Change
Profit	$738.0K	↓ 18.27%

	Q2 FY25	Q/Q Change
Profit	$1.3M	↑ 81.84%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$8.3M	↓ 168.2%
Investing Cash Flow	$-6.9M	↓ 59.52%
Financing Cash Flow	$-1.0M	↓ 2286.96%

	FY20	Y/Y Change
Operating Cash Flow	$-6.9M	↓ 183.18%
Investing Cash Flow	$17.4M	↓ 352.07%
Financing Cash Flow	$-629.0K	↓ 37.48%

	FY21	Y/Y Change
Operating Cash Flow	$-8.9M	↑ 29.31%
Investing Cash Flow	$3.5M	↓ 79.59%
Financing Cash Flow	$-1.1M	↑ 66.93%

	FY22	Y/Y Change
Operating Cash Flow	$-11.9M	↑ 33.3%
Investing Cash Flow	$-481.0K	↓ 113.56%
Financing Cash Flow	$35.8M	↓ 3506.1%

	FY23	Y/Y Change
Operating Cash Flow	$-10.5M	↓ 11.95%
Investing Cash Flow	$-34.3M	↑ 7035.34%
Financing Cash Flow	$22.9M	↓ 35.92%

	FY24	Y/Y Change
Operating Cash Flow	$-13.6M	↑ 30.19%
Investing Cash Flow	$-8.4M	↓ 75.53%
Financing Cash Flow	$19.4M	↓ 15.37%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-4.0M	↑ 121.95%
Investing Cash Flow	$-2.4M	↓ 150.08%
Financing Cash Flow	$-699.0K	↑ 242.65%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-3.6M	↓ 9.49%
Investing Cash Flow	$2.8M	↓ 219.09%
Financing Cash Flow	$-103.0K	↓ 85.26%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-3.8M	↑ 3.67%
Investing Cash Flow	$-14.3M	↓ 602.14%
Financing Cash Flow	$20.7M	↓ 20205.83%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-1.6M	↓ 56.42%
Investing Cash Flow	$4.8M	↓ 133.8%
Financing Cash Flow	$-513.0K	↓ 102.48%

Mediwound Technicals Summary

Sell

Neutral

Buy

Mediwound is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mediwound Ltd Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mediwound Ltd	-14.91%	-6.31%	-6.96%	23.0%	-19.39%
Regeneron Pharmaceuticals, Inc.	5.39%	-15.07%	-50.13%	-3.42%	-0.61%
Beone Medicines Ltd	4.61%	26.63%	56.19%	78.75%	30.26%
Vertex Pharmaceuticals Incorporated	-16.11%	-17.89%	-18.87%	34.22%	47.47%
Alnylam Pharmaceuticals, Inc.	40.82%	82.49%	64.08%	110.21%	247.67%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mediwound Ltd	NA	NA	-0.07	-2.9	-1.49	-0.22	NA	1.85
Regeneron Pharmaceuticals, Inc.	14.47	14.47	1.18	39.36	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.33	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.73	27.73	0.58	18.04	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mediwound Ltd	Buy	$191.4M	-19.39%	NA	-142.18%
Regeneron Pharmaceuticals, Inc.	Buy	$60.8B	-0.61%	14.47	31.37%
Beone Medicines Ltd	NA	$38.5B	30.26%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.0B	47.47%	27.73	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$60.1B	247.67%	NA	-12.96%

About Mediwound Ltd

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Organization	Mediwound
Employees	111
CEO	Mr. Ofer Gonen B.Sc.
Industry	Health Technology

Key Management of Mediwound Ltd

Name	Title
Mr. Ofer Gonen B.Sc.	Chief Executive Officer
Ms. Hani Luxenburg	Chief Financial Officer
Dr. Shmulik Hess Ph.D.	COO & Chief Commercial Officer
Mr. Yaron Meyer Adv.	Executive VP, General Counsel & Corporate Secretary
Dr. Ety Klinger MBA, Ph.D.	Chief Research & Development Officer
Mr. Barry J. Wolfenson	Executive Vice President of Strategy & Corporate Development
Ms. Hagit Mashiach	VP of Human Resources
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.	Chief Medical Officer

Important FAQs about investing in MDWD Stock from India :

What is Mediwound share price today?

Mediwound share price today is $17.44 as on August 22, 2025 at 12:36 AM IST. Mediwound share today touched a day high of $17.49 and a low of $17.44.

What is the 52 week high and 52 week low for Mediwound share?

Mediwound share touched a 52 week high of $22.51 and a 52 week low of $14.14. Mediwound stock price today i.e. August 22, 2025 at 12:36 AM IST is trending at $17.44, lower by 22.51% versus the 52 week high.

How to invest in Mediwound Stock (MDWD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mediwound on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mediwound Shares that will get you 0.0860 shares as per Mediwound share price of $17.44 per share as on August 22, 2025 at 12:36 AM IST.

What is the minimum amount required to buy Mediwound Stock (MDWD) from India?

Indian investors can start investing in Mediwound (MDWD) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Mediwound stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Mediwound share’s latest price of $17.44 as on August 22, 2025 at 12:36 AM IST, you will get 0.5734 shares of Mediwound. Learn more about fractional shares .

What are the returns that Mediwound has given to Indian investors in the last 5 years?

Mediwound stock has given -19.39% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?